Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Kurtz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Pharmacy|December 1, 1987
Treatment of panic and phobic disordersM W Jann, N M Kurtz
Journal of Clinical Psychopharmacology|February 1, 1987
What is the degree of risk of hepatotoxicity for depressed patients receiving phenelzine therapy? Is the risk sufficient to require that we modify the written advice (as to diet and risks) that we regularly give our patients before we institute this therapy?D S Robinson, N M Kurtz
Clinical Chemistry|November 1, 1976
Error introduced by specimen handling before determination of inorganic phosphate concentrations in plasma and serumJ E Carothers, N M Kurtz, J Lemann
Psychosomatics|September 1, 1984
Progressive supranuclear palsy presenting as pseudodementiaJ Z Sadler, N M Kurtz, A J Rush
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Psychopharmacology Bulletin|January 1, 1990
Ipsapirone: evidence for efficacy in depressionA H Heller, M Beneke, B Kuemmel, et al.
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
Psychopharmacology Bulletin|January 1, 1988
A 5-HT1A ligand with both antidepressant and anxiolytic propertiesJ M Cott, N M Kurtz, D S Robinson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
The Annals of Pharmacotherapy|June 1, 1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patientsN R Cutler, J J Sramek, A Luna, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacy|December 1, 1987
Treatment of panic and phobic disordersM W Jann, N M Kurtz
Journal of Clinical Psychopharmacology|February 1, 1987
What is the degree of risk of hepatotoxicity for depressed patients receiving phenelzine therapy? Is the risk sufficient to require that we modify the written advice (as to diet and risks) that we regularly give our patients before we institute this therapy?D S Robinson, N M Kurtz
Clinical Chemistry|November 1, 1976
Error introduced by specimen handling before determination of inorganic phosphate concentrations in plasma and serumJ E Carothers, N M Kurtz, J Lemann
Psychosomatics|September 1, 1984
Progressive supranuclear palsy presenting as pseudodementiaJ Z Sadler, N M Kurtz, A J Rush
The Annals of Pharmacotherapy|September 1, 1996
Placebo response in anxiety disordersM A Piercy, J J Sramek, N M Kurtz, et al.
Psychopharmacology Bulletin|January 1, 1990
Ipsapirone: evidence for efficacy in depressionA H Heller, M Beneke, B Kuemmel, et al.
The Annals of Pharmacotherapy|December 10, 1997
Ethnicity and antipsychotic responseE J Frackiewicz, J J Sramek, J M Herrera, et al.
Psychopharmacology Bulletin|January 1, 1988
A 5-HT1A ligand with both antidepressant and anxiolytic propertiesJ M Cott, N M Kurtz, D S Robinson, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
The Annals of Pharmacotherapy|June 1, 1996
Effect of the ACE inhibitor ceronapril on cerebral blood flow in hypertensive patientsN R Cutler, J J Sramek, A Luna, et al.
Pageof 2